DOCSLIB.ORG

The Future of Genomic Medicine IX Thursday, March 3 and Friday, March 4, 2016 • Scripps Institution of Oceanography • La Jolla, California

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Future of Genomic Medicine IX Thursday, March 3 and Friday, March 4, 2016 • Scripps Institution of Oceanography • La Jolla, California The Future of Genomic Medicine IX Thursday, March 3 and Friday, March 4, 2016 • Scripps Institution of Oceanography • La Jolla, California Presented in partnership with AAAS/Science Translational Medicine Course Introduction Conference Highlights • Voice of the patient represented Course Overview throughout the conference In collaboration with AAAS/Science Translational Medicine we invite you to • Renowned faculty representing the another exciting two day program on Thursday, March 3 and Friday, March country’s leading institutions • Multiple panel discussion segments 4, 2016 in beautiful San Diego, California. The 2016 program will again be with ample question and answer time with faculty held at Scripps Institution of Oceanography. • Additional networking opportunities The 9th Future of Genomic Medicine conference will be the next iteration Educational Objectives of taking genomic knowledge to transform the daily practice of medicine. After attending this activity, participants should be able to: To do this, we have patients present their story of how genomics affected • Demonstrate the unmet needs of their medical status, and have an international faculty of experts in genomics, medicine today with respect to more targeted, individualized prevention science and medical journalism, and the life science industry provide critical and treatments. perspective. This year we will be paying particular attention to the exciting • Discuss the opportunities of the genome, proteome, metabolome area of genomic editing to treat particular diseases, cancer (a disease of the discovery to change medical practice as it exists today. genome), and the genomics of rare and unknown diseases. Furthermore, we • Assess how changes and advances in will delve into to the hot topics of the microbiome, genomic-guided drug technology are rapidly ushering in a whole array of new pathways for therapies and genomic analytics. The overarching goal of the conference is individualized medicine of the future. to spearhead efforts to use genomic knowledge to change medicine and make • Explore specific strategies in cancer, idiopathic and pharmacogenomic it far more precise and individualized. futuristic interventions. We look forward to your participation and another successful conference. Target Audience • Physicians • Human geneticists • Genomic scientists • Researchers • Health care professionals of all Eric J. Topol, MD disciplines interested in the future Course Director of medicine, especially with respect to individualized therapies Disclosures and About Scripps Disclosure About Scripps Translational Science Institute Commercial Support The Scripps Translational Science Institute (STSI) aims to replace the status-quo This course is supported, in part, by educational of one-size-fits-all-medicine with individualized health care that is based on the grants from industry. At the time of printing, a known genetic factors influencing health and disease and that takes advantage complete listing of commercial supporters was of advances in digital technology for real-time health monitoring. not available. Appropriate acknowledgement will be given to all supporters at the time of the Since its founding in 2006 by Scripps Health, STSI has been distinguished by educational activity. its leadership in translational genomics and for harnessing digital, or wireless, medical technology for health monitoring of individual patients. In addition, it is Cultural and Linguistic Competency the only member of the National Institutes of Health’s Clinical and Translational This activity is in compliance with California As- Science Award (CTSA) consortium that is not affiliated with a university. sembly Bill 1195 which requires that all CME activities comprising a patient care element in- STSI hybridizes The Scripps Research Institute (TSRI) ‘s considerable biomedical clude curriculum addressing the topic of cultur- science expertise with Scripps Health’s exceptional patient care and clinical re- al and linguistic competency. The intent of this search. As a translational bridge between TSRI and Scripps Health, STSI fosters bill is to ensure that health care professionals innovative programs and methodology, provides an optimal setting for training are able to meet the cultural and linguistic con- and education and accelerates the conduct of studies that will have the greatest cerns of a diverse patient population through potential impact on the practice of health care in the clinic and the community. effective and appropriate professional develop- ment. Cultural and linguistic competency was For more information on the Scripps Translational Science Institute, visit incorporated into the planning of this activity. www.stsiweb.org. Faculty Course Director Eric J. Topol, MD George M. Church, PhD Tuuli Lappalainen, PhD Director Professor of Genetics Assistant Professor, Department of Scripps Translational Science Institute Harvard Medical School Systems Biology at Columbia University Chief Academic Officer, Scripps Health Director of Center for Junior Investigator and Core Member Professor of Genomics Computational Genetics New York Genome Center Boston, Massachusetts New York City, New York The Scripps Research Institute La Jolla, California Mirza Cifric David H. Ledbetter, PhD, FACMG F o u n d e r a n d C h i e f E x e c u t i v e O f fi c e r Executive Vice President and Veritas Genetics Chief Scientific Officer Planning Committee Boston, Massachusetts Geisinger’s Autism & Developmental Kristian Andersen, PhD Medicine Institute (ADMI) Assistant Professor Andrew J. Conrad, PhD Lewisburg, Pennsylvania The Scripps Research Institute Chief Executive Officer Director, Infectious Disease Genomics Google Life Sciences Nick Leschly Scripps Translational Science Institute Mountain View, California Chief Executive Officer La Jolla, California Bluebird Bio Chad Cowan, PhD Cambridge, Massachusetts Laura Nicholson, MD, PhD Harvard University Department of Co-Director of Education Stem Cell and Regenerative Biology Elisa Long, PhD Scripps Translational Science Institute Massachusetts General Hospital Assistant Professor in Decisions, Associate Program Director, Medicine Cambridge, Massachusetts Operations & Technology Management Residency, Scripps Green Hospital University of California, Los Angeles Zubin Damania, MD Los Angeles, California La Jolla, California Chief Executive Officer Emily Spencer, PhD Turntable Health Elaine R. Mardis, PhD Assistant Professor Chief Rapper, ZDogg LLC Robert E. and Louise F. Dunn Scripps Translational Science Institute Las Vegas, Nevada Distinguished Professor of Medicine Co-director, McDonnell Genome Director, Clinical Genomics Program Helmy Eltoukhy, PhD La Jolla, California Institute at Washington University Chief Executive Officer St. Louis, Missouri Steven R. Steinhubl, MD Guardant Health Director of Digital Medicine Redwood City, California Jessica Richman Scripps Translational Science Institute Co-Founder Elad Gil uBiome La Jolla, California Chief Executive Officer Andrew Su, PhD Color Genomics Beth A. Shapiro, DPhil Associate Professor San Francisco, California Associate Professor Department of Ecology & The Scripps Research Institute David B. Goldstein, PhD La Jolla, California Evolutionary Biology Director University of California, Santa Cruz Ali Torkamani, PhD Institute for Genomic Medicine Santa Cruz, California Director of Genome Informatics and New York City, New York Patrick Soon-Shiong, MD Drug Discovery Robert C. Green, MD, MPH Scripps Translational Science Institute Surgeon and Medical Researcher Director University of California, Los Angeles Assistant Professor of Molecular and Genomes2People Research Program Experimental Medicine Businessman and Philanthropist Division of Genetics Los Angeles, California The Scripps Research Institute Brigham and Women’s Hospital, Broad La Jolla, California Institute and Harvard Medical School Victor E. Velculescu, MD, PhD Co-Director, Cancer Biology Nathan E. Wineinger, PhD Boston, Massachusetts Assistant Professor Professor, Oncology and Pathology Hakon Hakonarson, MD, PhD Johns Hopkins University Director of Biostatistics Director, Center for Applied Genomics Scripps Translational Science Institute Kimmel Cancer Center The Children’s Hospital of Philadelphia Baltimore, Maryland La Jolla, California University of Pennsylvania School of Medicine Ron Winslow Faculty Philadelphia, Pennsylvania Deputy Editor, Health and Science and Senior Medical and Health Care Writer Gonçalo Abecasis, PhD David Haussler, PhD Wall Street Journal Chair Department of Biostatistics Investigator School of Public Health Howard Hughes Medical Institute Anne E. Wojcicki University of Michigan Scientific Director Chief Executive Officer and Co-Founder Ann Arbor, Michigan UC Santa Cruz Genomics Institute 23andMe Santa Cruz, California Mountain View, California Atul Butte, MD, PhD Director Erika Check Hayden Institute for Computational Health Sciences Reporter, Nature University of California, San Francisco Professor Executive Director for Clinical Informatics University of California, Santa Cruz University of California Health San Francisco, California San Francisco, California Elizabeth Holmes Charles Chiu, MD, PhD Chief Executive Officer Associate Professor Theranos Laboratory Medicine and Medicine Palo Alto, California Infectious Diseases Leroy Hood, MD, PhD University of California, San Francisco President San Francisco, California Institute for Systems Biology Seattle, Washington Agenda Thursday, March 3, 2016 Afternoon
Load more

Recommended publications
  • Guardant Health, Inc. Form 8-K Current Event Report Filed 2019-01
    SECURITIES AND EXCHANGE COMMISSION FORM 8-K Current report filing Filing Date: 2019-01-07 | Period of Report: 2019-01-07 SEC Accession No. 0001628280-19-000132 (HTML Version on secdatabase.com) FILER Guardant Health, Inc. Mailing Address Business Address 505 PENOBSCOT DR. 505 PENOBSCOT DR. CIK:1576280| IRS No.: 454139254 | State of Incorp.:DE | Fiscal Year End: 1231 REDWOOD CITY CA 94063 REDWOOD CITY CA 94063 Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 19512177 855-698-8887 SIC: 8071 Medical laboratories Copyright © 2019 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 7, 2019 GUARDANT HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 0001-576280 45-4139254 (State or other jurisdiction (Commission (I.R.S. Employer of incorporation or organization) File Number) Identification No.) 505 Penobscot Dr. Redwood City, California 94063 (Address of principal executive offices) (Zip Code) 855-698-8887 (Registrant’s telephone number, include area code) N/A (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ¨ Written communications pursuant to Rule 425 under
    [Show full text]
  • Artificial Intelligence in Health Care: the Hope, the Hype, the Promise, the Peril
    Artificial Intelligence in Health Care: The Hope, the Hype, the Promise, the Peril Michael Matheny, Sonoo Thadaney Israni, Mahnoor Ahmed, and Danielle Whicher, Editors WASHINGTON, DC NAM.EDU PREPUBLICATION COPY - Uncorrected Proofs NATIONAL ACADEMY OF MEDICINE • 500 Fifth Street, NW • WASHINGTON, DC 20001 NOTICE: This publication has undergone peer review according to procedures established by the National Academy of Medicine (NAM). Publication by the NAM worthy of public attention, but does not constitute endorsement of conclusions and recommendationssignifies that it is the by productthe NAM. of The a carefully views presented considered in processthis publication and is a contributionare those of individual contributors and do not represent formal consensus positions of the authors’ organizations; the NAM; or the National Academies of Sciences, Engineering, and Medicine. Library of Congress Cataloging-in-Publication Data to Come Copyright 2019 by the National Academy of Sciences. All rights reserved. Printed in the United States of America. Suggested citation: Matheny, M., S. Thadaney Israni, M. Ahmed, and D. Whicher, Editors. 2019. Artificial Intelligence in Health Care: The Hope, the Hype, the Promise, the Peril. NAM Special Publication. Washington, DC: National Academy of Medicine. PREPUBLICATION COPY - Uncorrected Proofs “Knowing is not enough; we must apply. Willing is not enough; we must do.” --GOETHE PREPUBLICATION COPY - Uncorrected Proofs ABOUT THE NATIONAL ACADEMY OF MEDICINE The National Academy of Medicine is one of three Academies constituting the Nation- al Academies of Sciences, Engineering, and Medicine (the National Academies). The Na- tional Academies provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions.
    [Show full text]
  • NHS England Briefed Against Gps
    this week NHS RESERVES page 381 • MESH CLINICS page 382 • LIVERPOOL TESTING page 384 LMCs: NHS England briefed against GPs GP leaders have demanded that NHS chair of the BMA’s General Practitioners The BMA’s Richard Vautrey England and NHS Improvement apologise Committee, writing to the NHS chief said it seemed NHS England and retract any communications that may executive, Simon Stevens, asking for had “intentionally sought have harmed their reputation or incited NHSE/I to “apologise to the profession and to create negative media coverage of primary care” complaints by implying that practices had correct damage that has been done.” not been fully involved in care of patients Vautrey wrote, “Implying within the throughout the covid-19 pandemic. press release that GPs are not providing A motion passed at the annual patients with the appointments they conference of England’s local medical need and ‘reminding’ them that they face committees on 27 November said that ‘enforcement action’ if they do not has much of NHSE/I’s communications with presented NHSE/I as antagonistic and GPs, the press, and the public had been completely out of touch with the profession. “abhorrent and insulting.” The conference It also seems to many GPs that NHSE/I has, called for NHSE/I to recognise general by using this tactic, intentionally sought to LATEST ONLINE practice’s contribution to the management create negative media coverage of primary of the pandemic and the continuation of care services. Test for HIV normal service, “particularly given the “The BMA is now hearing large numbers wherever blood is general practitioners who have died in the of reports from practices receiving taken, recommends course of their duties to the public.” complaints and many staff members being UK independent The motion added that it “deplores verbally abused by the public based on commission the habit” of briefi ng journalists before these unsupported and ill-informed media Declarations of communicating with the profession and its articles.
    [Show full text]
  • 2004 Albert Lasker Nomination Form
    albert and mary lasker foundation 110 East 42nd Street Suite 1300 New York, ny 10017 November 3, 2003 tel 212 286-0222 fax 212 286-0924 Greetings: www.laskerfoundation.org james w. fordyce On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination Chairman neen hunt, ed.d. for the 2004 Albert Lasker Medical Research Awards. President mrs. anne b. fordyce The Awards will be offered in three categories: Basic Medical Research, Clinical Medical Vice President Research, and Special Achievement in Medical Science. This is the 59th year of these christopher w. brody Treasurer awards. Since the program was first established in 1944, 68 Lasker Laureates have later w. michael brown Secretary won Nobel Prizes. Additional information on previous Lasker Laureates can be found jordan u. gutterman, m.d. online at our web site http://www.laskerfoundation.org. Representative Albert Lasker Medical Research Awards Program Nominations that have been made in previous years may be updated and resubmitted in purnell w. choppin, m.d. accordance with the instructions on page 2 of this nomination booklet. daniel e. koshland, jr., ph.d. mrs. william mccormick blair, jr. the honorable mark o. hatfied Nominations should be received by the Foundation no later than February 2, 2004. Directors Emeritus A distinguished panel of jurors will select the scientists to be honored. The 2004 Albert Lasker Medical Research Awards will be presented at a luncheon ceremony given by the Foundation in New York City on Friday, October 1, 2004. Sincerely, Joseph L. Goldstein, M.D. Chairman, Awards Jury Albert Lasker Medical Research Awards ALBERT LASKER MEDICAL2004 RESEARCH AWARDS PURPOSE AND DESCRIPTION OF THE AWARDS The major purpose of these Awards is to recognize and honor individuals who have made signifi- cant contributions in basic or clinical research in diseases that are the main cause of death and disability.
    [Show full text]
  • Guardant Health, Inc. Form 10-Q Quarterly Report Filed 2021-08-05
    SECURITIES AND EXCHANGE COMMISSION FORM 10-Q Quarterly report pursuant to sections 13 or 15(d) Filing Date: 2021-08-05 | Period of Report: 2021-06-30 SEC Accession No. 0001576280-21-000080 (HTML Version on secdatabase.com) FILER Guardant Health, Inc. Mailing Address Business Address 505 PENOBSCOT DR. 505 PENOBSCOT DR. CIK:1576280| IRS No.: 454139254 | State of Incorp.:DE | Fiscal Year End: 1231 REDWOOD CITY CA 94063 REDWOOD CITY CA 94063 Type: 10-Q | Act: 34 | File No.: 001-38683 | Film No.: 211148786 855-698-8887 SIC: 8071 Medical laboratories Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _____________________ FORM 10-Q _____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38683 _____________________ GUARDANT HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) _____________________ Delaware 45-4139254 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 505 Penobscot Dr. Redwood City, California, 94063 Registrant’s telephone number, including area code: (855) 698-8887 _______________ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • A Review of J. Craig Venter's a Life Decoded
    A peer-reviewed electronic journal published by the Institute for Ethics and Emerging Technologies ISSN 1541-0099 17(1) – March 2008 A review of J. Craig Venter’s A Life Decoded Randy Mayes, Duke University Journal of Evolution and Technology - Vol. 17 Issue 1 – March 2008 - pgs 71-72 http://jetpress.org/v17/mayes.htm In the early 1980s, a number of researchers suggested sequencing and mapping the human genome to help the science community better understand diseases and evolution. Following the announcement that the human genome had been sequenced, scientists wrote in peer-reviewed journals that we are not as hardwired as was once believed, and that the sequencing of the genome was just the beginning. Today, researchers have a new set of goals. In popular journalism, however, the science was lost in the shuffle. The media focused more on the dynamics of the conflicting philosophies of the private and public projects. This emphasis is also clear in the titles of several books chronicling the Human Genome Project, all appearing prior to the recent release of Craig Venter’s autobiography, A Life Decoded: My Genome: My Life (2007). Readers will find that Robert Cook-Deegan’s The Gene Wars (1995) and The Common Thread by Sir John Sulston and Georgina Ferry (2002), both written by insiders, are biased towards the philosophy of the public project, a commons approach. Sulston is a socialist who grows runner beans and drives a second hand car. By contrast, Venter travels in Lear jets and conducts business from his yacht. Three other books are more objective.
    [Show full text]
  • Award Recipients Award Consists of a Plaque and a Cash Stipend
    SOT HONOR AND AWARD DESCRIPTIONS AND HISTORY In recognition of distinguished toxicologists and students, Nominations for many awards must be submitted by a sponsor SOT presents Honorary Membership and Awards each year. and a seconder who are Full members of SOT using the online In addition to receiving a plaque, recipients are honored Award Nomination form. The supporting documentation at a special Awards Ceremony at the SOT Annual Meeting must indicate the candidate’s achievements in toxicology and and their names are listed in SOT publications. The deadline is critical in the review of each application. See the award for 2013 Honorary Membership and Award nominations is description for the additional requirements and details. There October 9, 2012. are specific applications for Fellowships and Graduate Student Travel Support. SOT Council reviews nominations for Honorary Membership and the Awards Committee reviews applications for SOT Other graduate student and postdoctoral fellow awards are Awards and most Sponsored Awards. Awards Committee available through Regional Chapters, Special Interest Groups, members are not eligible to receive any awards conferred by and Specialty Sections (many of these awards are funded the Committee while serving on the Committee and for one through the various Named Endowment Funds). A student or subsequent year. postdoctoral scholar may apply for any award for which he or she is eligible and may apply for and receive multiple awards, The Best Paper Awards in Toxicological Sciences are reviewed whether SOT, Regional Chapters, Special Interest Groups, or by the Board of Publications. The Education Committee selects Specialty Sections administrators the awards. Policies related the recipients of the Pfizer Undergraduate Travel Award and to travel support are determined by the sponsor (SOT, the Committee on Diversity Initiatives selects the recipients Regional Chapter, Special Interest Group, or Specialty Section).
    [Show full text]
  • Patients First
    04 Patients First PATIENTS FIRST THE CLEVELAND CLINIC 2004 ANNUAL REPORT 1 “Patients First” > On Oct. 1, 2004, The Cleveland Clinic welcomed Delos M. Cosgrove, M.D., as its new Chief Executive Offi cer and President. With the inauguration of Dr. Cosgrove, The Cleveland Clinic has rededicated itself to one of the most sacred principles of medicine: “Patients First.” This prin- ciple declares the primacy of patient care, patient comfort and patient communication in every activity undertaken by The Cleveland Clinic. It affi rms the importance of research and education for their contributions to clinical medicine and the improvement of patient care. At the same time, “Patients First” demands a relentless focus on measurable quality. By setting standards, collecting data and analyzing results, The Cleveland Clinic puts patients fi rst through improved outcomes, better service and by providing a healthier future for all. PATIENTS FIRST THE CLEVELAND CLINIC 2004 ANNUAL REPORT 2 Dear Friends: In 2004, The Cleveland Clinic enjoyed the best year in its and visitor spending. We are currently the largest employer history. We helped more patients and contributed more in Northeast Ohio, and the third largest non-governmental to our local and regional economies than ever before. The employer in the state. Our economic activities create ad- number of patient visits, surgeries and hospital admis- ditional jobs in the community, for a total of 65,000 jobs sions at The Cleveland Clinic and Cleveland Clinic Health overall. We are responsible for direct and indirect state System have surpassed all previous years. Working as a and local taxes totaling $300 million – including one out team, we are building, educating and innovating for the of every 10 tax dollars collected in the city of Cleveland.
    [Show full text]
  • DOE Human Genome Program Contractor-Grantee Workshop III
    ORNL/M-2588 uman enome Program U.S. Department of Energy Contractor-Grantee Workshop III February 7-10, 1993 Santa Fe, New Mexico Date Published: January 1993 Prepared for the U.S. Department of Energy Office of Energy Research Office of Health and Environmental Research Washington, D.C. 20585 under budget and reporting code KP 0404000 Prepared by Human Genome Management Information System Oak Ridge National Laboratory Oak Ridge, TN 37831-6050 Managed by MARTIN MARIETTA ENERGY SYSTEMS, INC. for the U.S. DEPARTMENT OF ENERGY UNDER CONTRACT DE-AC05-840R21400 ., Contents Workshop Agenda v-vii Poster Presentation Times viii Introduction To The Santa Fe Workshop ix Abstracts* U.S. Department of Energy Laboratories Human Genome Centers LANL-Los Alamos National Laboratory (1-20) LBL-Lawrence Berkeley Laboratory (21-48) LLNL-Lawrence Livermore National Laboratory (49-75) Ames Research Center (76) ANL-Argonne National Laboratory (77-80) BNL-Brookhaven National Laboratory (81) LANL-Los Alamos National Laboratory (82-90) LBL-Lawrence Berkeley Laboratory (91-96) ORNL-Oak Ridge National Laboratory (97-109) PNL-Pacific Northwest Laboratory (110-111) Other Institutions (112-198) Appendices A. Subject Index 199 B. Author Index 200 C. Anticipated Workshop Attendees 207 'Each section alphabetized by first author. iii Workshop Agenda DOE Human Genome Program Contractor-Grantee Workshop ill Santa Fe, NM February 7-10, 1993 Plenary sessions are in the Eldorado, poster sessions are in the Hilton. Each speaker and demonstration in the plenary sessions will have an abstract number, and thus a poster, associated with the talk. Schedule correct as of January 15, 1993.
    [Show full text]
  • Anatomy and Atrophy of Medical Paternalism Robert F
    Anatomy and Atrophy of Medical Paternalism Robert F. Graboyes and Eric Topol MERCATUS RESEARCH Robert F. Graboyes and Eric Topol, “Anatomy and Atrophy of Medical Paternalism” (Mercatus Research, Mercatus Center at George Mason University, Arlington, VA, 2017). ABSTRACT Since Ancient Greece, a guiding principle of Western medicine has been pater- nalism—the idea that doctors have intrinsically superior insights, patients should defer to their edicts, and this asymmetry is a desirable state of affairs. In the 20th century, new medical knowledge and technologies accumulated at an unprecedented rate, and medical paternalism arguably reached its zenith. Now, however, new technologies are eroding the doctor’s privileged role by deconstructing, digitizing, and democratizing medical knowledge. Digital technologies and other breakthroughs offer unprecedented opportunities to save lives and cut costs. Along with self-interest, however, selective strains of risk aversion, technophobia, and egalitarianism among physicians are gener- ating resistance to the new reality. This article catalogs the motives for and impact of medical paternalism, the reasons for its decline, and potential policy responses that would ease the transition. JEL codes: I11, I13, I18, K2 Keywords: health care, healthcare, medicine, physician, doctors, consumer sov- ereignty, licensure, certification, regulation, prices, technology, digital health The Mercatus Center gratefully acknowledges the financial support of the John Templeton Foundation for research on healthcare policy in the United States. Copyright © 2017 by Robert F. Graboyes, Eric Topol, and the Mercatus Center at George Mason University The views expressed in Mercatus Research are the authors’ and do not represent official positions of the Mercatus Center or George Mason University. Patients .
    [Show full text]
  • Case Study: Leroy Hood / February 10, 2021
    Case Study: Leroy Hood / February 10, 2021 CASE STUDY: LEROY HOOD Introduction Leroy Hood is an inventor, entrepreneur, and in the vanguard of molecular biotechnology and genomics. He co-founded systems biology: an interdisciplinary, holistic approach to biomedical research that focuses on how molecules operate together. His inventions include the gas liquid phase protein sequencer, protein synthesizer, DNA sequencer, DNA synthesizer, the ink-jet-based DNA synthesizer (large-scale DNA synthesis) and the nanostring technology for single-molecule DNA and RNA analyses. Taken together, these six instruments have formed the technological foundation for much of the research conducted in the biotechnology- and genomics-related fields today. Hood received the Lemelson- MIT Prize in 2003 for his revolutionary innovations, which led to new, comprehensive knowledge of the factors that contribute to human disease and Leroy Hood (Photo/Dale DeGabriele) wellness. Background and Early Life Born between mountain ranges in Missoula, Montana, Leroy Hood cultivated an early fascination with the natural world and a lifelong affinity for physical fitness. He spent much of his childhood at his grandfather’s ranch in the Beartooth Mountains, and his family encouraged exploration, independence and excellence in all endeavors. Hood’s interest in biology began with the birth of his younger brother who was diagnosed with Down syndrome. At the time, the scientific community had no way of explaining why some babies were born with this condition, and Hood’s curiosity about biological conundrums and the human complexities they dictated began to grow. Hood’s family moved to Shelby, Montana, at the start of his high school career.
    [Show full text]
  • Commencement
    UN IVERS IT Y 0 F R 0 CHESTER 0 N E HUN 0 R E 0 SIXTY~ FIRST COMMENCEMENT MAY 2011 Introduction, 4 Honorary Awards, 5 Honor Societies and Awards, 1 0 Doctoral Degree Candidates, 14 Doctor of Philosophy, 14 School of Nursing, 15 Doctor of Nursing Practice, 15 Eastman School of Music_, 16 Doctor of Musical Arts, 16 Doctor of Education, 16 Degree Candidates, 17 School of Arts and Sciences, 1 7 Bachelor of Arts, 17 Bachelor of Science, 22 Master of Arts, 25 Master of Science, 26 Bachelor of Arts, 2 7 Bachelor of Science, 27 Master of Science, 28 Eastman School of Music, 30 Bachelor of Music, 30 Master of Arts, 31 Master of Music, 31 School of Medicine and Dentistry, 32 Master of Arts, 32 M aster of Science, 32 M aster of Public Health, 32 Doctor of M edicine and Doctor of Philosophy, 33 Doctor of M edicine and Doctor of Philosophy with Distinction in Research, 33 Doctor of M edicine with Distinction in Research and with Distinction in Community Service, 33 Doctor of Medicine with Distinction in Research, 33 Doctor of M edicine with Distinction in Community Service, 33 Doctor of M edicine, 33 William E. Simon <L;raduate School of Business Administration, 34 School of Nursing, 35 Bachelor of Science, 35 M aster of Science, 36 M argaret Warner Graduate School of Education and Human Development, 37 M aster of Science, 37 The Genesee, 39 Campus M ap, 40 Jntrodu( lion ARich Tradition at Rochester The commencement season has always stnod out as the of the l:n iversity, and two silver bands are engraved with the "supreme festival" on Rochester 's academic calendar, Arthur names ' >f the Cniversity's presidents.
    [Show full text]